| Nomenclature | MET proto‐oncogene, receptor tyrosine kinase | macrophage stimulating 1 receptor |
| Common abreviation | MET | Ron |
| HGNC, UniProt | MET, P08581 | MST1R, Q04912 |
| EC number | 2.7.10.1 | 2.7.10.1 |
| Endogenous ligands | hepatocyte growth factor (HGF, P14210) | macrophage stimulating protein 1 (MST1, P09603) |
| Inhibitors | capmatinib (pIC50 9.9) [112], SGX‐523 (pK d 9.7) [38], PHA‐665752 (pK d 9.6) [38], foretinib (pIC50 9.3–9.4) [106, 137], cabozantinib (pIC50 8.9) [203], foretinib (pK d 8.9) [38], MK‐2461 (pIC50 8.6) [146], BMS‐777607 (pIC50 8.4) [164], PHA‐665752 (pK i 8.4) [26], SU11274 (pIC50 8) [190], golvatinib (pIC50 7.8) [139], tivantinib (pK i 6.4) [135] | BMS‐777607 (pIC50 8.7) [164] |
| Selective inhibitors | SGX‐523 (pIC50 8.4) [19] | – |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.